Home › Funds › Commodore Capital LP › SGMT
Commodore Capital LP position in SGMT
SAGIMET BIOSCIENCES INC · Health Care
Commodore Capital LP reported holding 2,757,742 shares of SGMT (SAGIMET BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$27.2M, representing 2.11% of its reported portfolio and ranking #15 among its reported holdings. Commodore Capital LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Commodore Capital LP's SGMT position evolved
Commodore Capital LP first disclosed a stake in SGMT in Q3 2026 at 2,757,742 shares (US$27.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 2.76M | $27.25M | New |
About SGMT and 13F data
SGMT (SAGIMET BIOSCIENCES INC) is a Health Care company. 61 other funds we track also report a position in SGMT — the largest reported positions include SILVERARC CAPITAL MANAGEMENT, LLC (US$37.0M), BVF INC/IL (US$34.6M), Caligan Partners LP (US$27.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SGMT
- SILVERARC CAPITAL MANAGEMENT, LLC 3.75M sh · $37.01M · Q3 2026
- BVF INC/IL 3.50M sh · $34.58M · Q3 2026
- Caligan Partners LP 2.79M sh · $27.61M · Q3 2026
- Affinity Asset Advisors, LLC 2.53M sh · $24.97M · Q3 2026
- Saturn V Capital Management LP 2.00M sh · $19.79M · Q3 2026
- GREAT POINT PARTNERS LLC 1.96M sh · $19.38M · Q3 2026
- Spruce Street Capital LP 1.40M sh · $13.83M · Q3 2026
- Atom Investors LP 725.92K sh · $7.17M · Q3 2026
- Jones Hill Capital LP 502.59K sh · $4.97M · Q3 2026
- Seven Fleet Capital Management LP 429.11K sh · $4.24M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 423.01K sh · $4.18M · Q3 2026
- Palo Alto Investors LP 250.00K sh · $2.47M · Q3 2026
More on Commodore Capital LP
FAQ
How long has Commodore Capital LP held SGMT?
Commodore Capital LP has disclosed SGMT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Commodore Capital LP's current position in SGMT?
As of Q3 2026, Commodore Capital LP holds 2.76M shares of SGMT (SAGIMET BIOSCIENCES INC), valued at $27.25M, representing 2.11% of its reported portfolio and ranking #15.
Has Commodore Capital LP been buying or selling SGMT?
In the latest 13F filing (Q3 2026), Commodore Capital LP newly opened its position in SGMT.
Which other funds hold SGMT?
Other major institutional holders of SGMT include SILVERARC CAPITAL MANAGEMENT, LLC, BVF INC/IL, Caligan Partners LP, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.